Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06255951
Status:
RECRUITING
Last Update Posted:
2024-02-26
First Post:
2024-01-17
Brief Title:
Studies Evaluating the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of TY-9591 Tablets in Healthy Subjects
Sponsor:
TYK Medicines Inc
Organization:
TYK Medicines Inc
Study Overview
Official Title:
This is a Single-center Two-sequence Open-label Two-cycle Drug-drug Interaction DDI Study in Healthy Subjects To Evaluate the Effects of Itraconazole Capsules a Strong Inhibitor of CYP3A4 and Rifampicin Capsules a Strong Inducer on the Pharmacokinetics of TY-9591 Tablets After a Single Oral Dose
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Studies evaluating the effects of itraconazole or rifampicin on the pharmacokinetics of TY-9591 tablets in healthy subjects
Detailed Description:
To evaluate the pharmacokinetics of TY-9591 tablets in healthy Chinese subjects after a single oral administration To evaluate the effects of itraconazolerifampicin on the pharmacokinetics of TY-9591 and its metabolites D1 and D2 after oral administration of TY-9591 tablets
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None